India to Cayman Islands: Ustekinumab Export Trade Route

The India to Cayman Islands Ustekinumab corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $4.5K USD. The route is dominated by MILES INTERNATIONAL, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $1.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with ustekinumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 18.4%, placing it at rank #19 among India's top ustekinumab export destinations globally.

On the import side, key buyers of Indian ustekinumab in Cayman Islands include TO THE ORDER OF THE PURCHASE MANAGE. TO THE ORDER OF THE PURCHASE MANAGE is the single largest importer with 3 shipments valued at $4.5K USD.

India's ustekinumab exports to Cayman Islands are driven primarily by a handful of large-scale manufacturers. MILES INTERNATIONAL with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Cayman Islands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MILES INTERNATIONAL — together account for 100% of total trade value on this route. The average shipment value of $1.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as [tax inv.no. wr000175] harmless pharmaceutical products: ustekinumab injection (stelera 90mg) and [tax inv.no. rbm05509] harmless pharmaceutical products: ustekinumab injection [stelara 90mg], suggesting that buyers in Cayman Islands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF THE PURCHASE MANAGE is the largest importer with 3 shipments worth $4.5K USD — representing 100% of all ustekinumab imports from India on this route.